Morphologically, APL is not a homogeneous entity; the classical hypergranular APL represents the great majority of all APL, and the microgranular variant accounts for about 15%-20% of all APL. In the classical hypergranular APL, there are abnormal promyelocytes with an abundant cytoplasm packed with large azurophilic granules. Auer bodies are commonly found in many cells. The microgranular variant is characterized by the presence of leukemic cells with bilobed or kidney-shaped nuclei with very minute granules in the cytoplasm that are not readily perceptible on light microscopy. [8] [9] [10] Appreciation of these morphological details is critical; the shortage of skilled and experienced morphologists in some setting means that slides have to be transported to specialized laboratories for review. 6 This leads to unnecessary diagnostic delays and may compromise patient's outcome. Many studies reported that parameters generated by automated blood cell counters have a possible role in aiding the diagnosis and classification of acute leukemia. [11] [12] [13] For example, Peroxidase Activity and Nuclear Density Analysis (PANDA) classification, based on the morphology of cell clusters on ADVIA 120 and 2120i, has been proposed and confirmed as a useful tool for a premicroscopic assessment of leukemic samples. 10, 14, 15 In this context, APL provides the most characteristic pattern among all leukemias as shown by D'Onofrio, Gibbs, and Pillay, because the MPO activity in promyelocytes is maximum and they are arranged on the extreme right of the perox channel and straddling the population of eosinophils ( Figure 1B-C) . [16] [17] [18] [19] [20] Another study led to design of a diagnostic algorithm for APL using as parameters the percentage of large unstained cells (LUC) and delta neutrophil index (DNI), but this work has been done on bone marrow aspiration fluid. 21 On the basis of these premises, and of the consideration that the evaluation of complete blood count (CBC) is the first test that the patient performs, often in emergency situations (access to Emergency
F I G U R E 1
Departments for hemorrhage), the purpose of our study was to build an algorithm that allows to produce a "APL criteria," on ADVIA 2120i
(Siemens), with high sensitivity and very high specificity, in order to alert biotechnologists and pathologists of the possible presence of the disease and not to burden on the loads working with the production of a high number of false positives.
| MATERIAL AND ME THODS

| Analyzer technology
The Siemens Advia 2120i (Siemens Healthcare Diagnostics, Deerfield, Illinois, USA) is an automated hematology analyzer that measures the total and differential WBC count using principles of flow cytometry and a combination of reactions that occur within the peroxidase and the basophil/nuclear lobularity channels. Cluster analysis of the cells within each channel is used to generate a cytogram and the pattern that emerges has been shown to assist with the subtyping of hematological malignancies.
10,14-18
| WBC count
The peroxidase channel is used to measure peroxidase activ- ( Figure 1A ).
| PLT count
The ADVIA 2120i uses a two-dimensional platelet analysis. This 
| Parameters used and construction of algorithm
All parameters entered in the algorithm were selected on the bases both the pathophysiology of the APL and the analyzer's technology.
They are represented by: 6. Increased % blasts: because, due to the reduced chromatin density of the APL cells, a portion higher than 4% exceeds the predetermined threshold and this causes these cells to be counted as blasts by the analyzer.
Considering the normal values of the above-mentioned parameters, supplied in default by the analyzer, and their characteristic alterations, we have chosen, for each of them, the following cutoff (cutoffs c1) to insert in the algorithm:
• PLT < 150 × 10 3 /μL;
• % Mono < 10;
• % LUC < 4;
• % hyperchromic cells > 2;
• % saturated cells ≥ 1;
• % blasts > 4.
Firstly, for each of the c1 cutoffs, the statistical significance was evaluated by comparing APL vs normal samples.
Subsequently, this algorithm was built on 247.209 sample files (raw-data), deriving from the emergency and routine samples provided by clinical laboratory of AORN "Rummo" (pilot laboratory).
With such cutoffs (c1), the algorithm A1 was constructed; the algorithm provided that at least five of six criteria must be verified in order to trigger the "APL criterion." With these c1 cutoffs, we have obtained an initial sensitivity and specificity value.
At this point, we kept the cutoff constant for five of the six parameters, varying time to time the sixth one and calculating sensitivity and specificity; those with higher sensitivity and specificity have been used as c2 cutoffs.
Then, to overcome the possible bias due to different calibrators (Siemens ADVIA 2120i SETpoint ™ Calibrator) and different analyzers, standardization used in other laboratories, the specificity of the algorithm for the APL-Flag, was tested on further 51.002 raw-data of peripheral blood samples (from routine and emergency) from two laboratories participating in the study.
To verify the specificity of this algorithm, with respect to interfering factors deriving from particular conditions, it has been tested on groups of patients affected from hematological and nonhematological diseases. It cannot be justifiable in these cases that almost all false positives are related to blood samples that should be lead to microscopic review.
The actions resulting from the suspicion of APL are so peculiar and urgent that many false positives could lead to the renunciation of the use of the flag;
2.
A total of 51.002 raw-data of CBC from routine and emergency assessed in a single group, coming from two others laboratories. (Table 1) The files were collected in the years 2014-17 in five laboratories involved in the study.
Hematological and nonhematological diseases
Clinical requests (CBC with differential formula, morphology, and cytofluorimetry) related to each case in the study were made by the clinicians as an integral part of the diagnostic process . No samples were requested from the patient for this study.
| Statistical analysis
We used raw-data provided by the ADVIA2120i (Siemens) for each sample, to obtain a full list with all the parameters provided by analyzer. Statistical analysis was performed using Microsoft Excel (Microsoft, Redmond, WA, USA) and MedCalc software version 11.4.2.0 (MedCalc, Ghent, Belgium). To test the distribution of the data, we used the D'Agostino-Pearson test because, for each group, we observed a P-value < 0.05 (data not fit a normal distribution); data were presented as median, minimum and maximum, and interquartile range (IRQ), and a nonparametric method was used . To display variation in groups, Box&Whishers distribution graphs were used; Mann-Whitney test was used to analyze association (a "P" value lower than 0.05 was considered statistically significant).
The main end-point of the study was the construction of an algorithm to predict the APL, so we used a group to build algorithm (247.209 samples from routine and emergency), and a group to validate it (51.002 samples from routine and emergency).
We used a univariate descriptive statistical analysis to compare groups and parameters individually.
The diagnostic accuracy of all cutoff points and algorithm was determined by calculating sensitivity and specificity tested on the groups APL-positive and on total routine and emergency APLnegative, respectively, toward individual groups of hematological and nonhematological diseases ; positive and negative predictive values (PPV and NPV) and likelihood ratios (LR+, LR−) have also been calculated.
| RE SULTS
| Normal samples vs APL: Comparative analysis
The comparison between normal samples and APL samples, respect to the selected and above-mentioned parameters, gave the following results; as expected, both for the platelet count and for the percentage of hyperchromic cells, as well as for the percentage of cells in saturation and the percentage of blasts, we found a statistically significant difference (Table 2) . Monocyte count and percentage of LUC, although in the normal range, showed a statistically significant trend (P < 0.05) at the lower limits ( Figure 2 and Table 2 ).
| Diagnostic accuracy for parameters in the study
Considering the statistically significant difference between normal and APL samples found for each individual parameter, it was decided to evaluate their diagnostic accuracy using cutoffs "c1" tested on the groups routine and emergency APL-negative and APL-positive (Table 3) .
Except for the % Iper, the "c1" cutoff showed a good sensitivity (>80%) for all parameters. About specificity, a low value is observed for monocytes and LUC parameters (Table 3) .
Then, these parameters with "c1" cutoffs were implemented in an algorithm A1, according to which at least five of six criteria had to be satisfied. This allowed to identify correctly the 89.16% of APL raw-data and the 99.65% of APL-negative samples.
Thus, to improve these cutoffs, we analyzed the individual parameters as described in the paragraph "Parameters and construction of the algorithm" and we obtained cutoffs "c2" (Table 3 ).
Through these "c2" cutoffs, it was possible to obtain a sensitiv- Data are given as median; min-max; IRQ. P-value is referred to comparison between normal samples and APL group, performed by MannWhitney U.
TA B L E 2
Comparison between normal samples and APL group oncologic samples or "reactive with hemolysis" samples or sample with glucose solution.
The algorithm, subsequently tested on the 51.002 raw-data deriving from the routine and from the emergency of two laboratories participating in the study, however, provided a high specificity (99.88%).
| APL vs other pathological groups: Comparative analysis
Then, it was evaluated A2 specificity in hematological and nonhematological diseases of certain diagnosis, whose raw-data were In the Megaloblastic Anemia group, the only false-positive sample met five of six required criteria (except for the % Iper).
( Table 4) TA TA B L E 4 Evaluation of specificity and sensitivity of the A2 algorithm in APL group and hematological and nonhematological diseases, respectively 
| D ISCUSS I ON
Complete blood count, differential count and review of peripheral blood smear usually are the first-line investigations that alert the clinician for a possible underlying leukemia, but further investigations are required to confirm the diagnosis and classify the leukemia before appropriate therapy can be started.
Acute promyelocytic leukemia, although it is the most curable of AML, is a hematological emergency since it requires prompt initiation of ATRA. Since the introduction of the drug in 1995, there has been a dramatic reduction in mortality and even early death. In reality, the rate of ED remains higher than estimated in clinical trials.
This, in part, can be attributed to delayed diagnosis or misdiagnoses.
Today diagnosis of haematological malignancy is an extremely complex procedure that usually includes: cellular morphology and immunophenotyping, cytogenetic, molecular studies. The very high specificity with a limited number of false positives allows to reduce the workloads, sparing the revision of unnecessary peripheral blood smears.
However, since it does not allow to alarm all the APL samples, we think that classical morphology is still mandatory.
In conclusion, the integration of this flag, instrumental and classical morphology, may allow to reduce the time of diagnosis in patients with Acute Promyelocytic Leukemia.
Since the algorithm was built retrospectively, it would be necessary to be tested prospectively in APL cases of new diagnosis.
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